Geron Corp (NASDAQ:GERN)

1.44
BATS BZX Real-Time Price
As of May 13
 0.00 / 0.00%
Today’s Change
0.99
Today|||52-Week Range
2.23
+18.03%
Year-to-Date
Why Geron Stock Is Soaring Today
May 10 / MotleyFool.com - Paid Partner Content
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
May 09 / Zacks.com - Paid Partner Content
Geron (GERN) Q1 2022 Earnings Call Transcript
May 10 / MotleyFool.com - Paid Partner Content
Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates
May 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.44
Today’s open1.47
Day’s range1.43 - 1.52
Volume93,095
Average volume (3 months)2,335,295
Market cap$547.3M
Data as of 4:00pm ET, 05/13/2022

Growth & Valuation

Earnings growth (last year)-27.21%
Earnings growth (this year)-10.29%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+450.59%
P/E ratioNM
Price/Sales286.94
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
SIGASIGA Technologies In...0.000.00%
SRNESorrento Therapeutic...0.000.00%
BCYCBicycle Therapeutics...0.000.00%
ATRAAtara Biotherapeutic...0.000.00%
Data as of 4:00pm ET, 05/13/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$1.4M
Annual profit (last year)-$116.1M
Net profit margin-8,335.39%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts